ArticleLaboratory investigation; a journal of technical methods and pathology2021

miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.

Jianmin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.